Ind-Swift, Wockhardt launch Atorvastatin tablets in UK
Atorvastatin (lipitor) is used for the treatment of high cholesterol and prevention of heart attack. The drug was launched in all the strengths including 10mg, 20mg, 40mg and
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.
The stabilized PTH formulations incorporate Aegis’ Intravail/ProTek excipients suitable for all routes of administration. Intravail and ProTek excipients allow for non-invasive delivery with high efficiency and stabilize, prevent
The investigational agent (tivozanib) has demonstrated statistically significant and clinically meaningful progression-free survival (PFS) superiority versus an approved targeted agent (sorafenib) in advanced RCC. AVEO Oncology president and